The University of Chicago Header Logo

Connection

Narutoshi Hibino to Tissue Engineering

Back to Details
This is a "connection" page, showing publications Narutoshi Hibino has written about Tissue Engineering.
Narutoshi Hibino
Connection Strength
11.967
Tissue Engineering
  1. Mechanical stimulation enhances development of scaffold-free, 3D-printed, engineered heart tissue grafts. J Tissue Eng Regen Med. 2021 05; 15(5):503-512.
    View in: PubMed
    Score: 0.684
  2. Principles of Spheroid Preparation for Creation of 3D Cardiac Tissue Using Biomaterial-Free Bioprinting. Methods Mol Biol. 2020; 2140:183-197.
    View in: PubMed
    Score: 0.627
  3. In vivo implantation of 3-dimensional printed customized branched tissue engineered vascular graft in a porcine model. J Thorac Cardiovasc Surg. 2020 05; 159(5):1971-1981.e1.
    View in: PubMed
    Score: 0.617
  4. Bioprinting of freestanding vascular grafts and the regulatory considerations for additively manufactured vascular prostheses. Transl Res. 2019 09; 211:123-138.
    View in: PubMed
    Score: 0.602
  5. A Net Mold-Based Method of Biomaterial-Free Three-Dimensional Cardiac Tissue Creation. Tissue Eng Part C Methods. 2019 04; 25(4):243-252.
    View in: PubMed
    Score: 0.595
  6. Formation of Neoarteries with Optimal Remodeling Using Rapidly Degrading Textile Vascular Grafts. Tissue Eng Part A. 2019 04; 25(7-8):632-641.
    View in: PubMed
    Score: 0.586
  7. A Net Mold-based Method of Scaffold-free Three-Dimensional Cardiac Tissue Creation. J Vis Exp. 2018 08 05; (138).
    View in: PubMed
    Score: 0.569
  8. In vivo therapeutic applications of cell spheroids. Biotechnol Adv. 2018 Mar - Apr; 36(2):494-505.
    View in: PubMed
    Score: 0.549
  9. Biomaterial-Free Three-Dimensional Bioprinting of Cardiac Tissue using Human Induced Pluripotent Stem Cell Derived Cardiomyocytes. Sci Rep. 2017 07 04; 7(1):4566.
    View in: PubMed
    Score: 0.527
  10. Creation of Cardiac Tissue Exhibiting Mechanical Integration of Spheroids Using 3D Bioprinting. J Vis Exp. 2017 07 02; (125).
    View in: PubMed
    Score: 0.527
  11. Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts. Tissue Eng Part A. 2018 01; 24(1-2):135-144.
    View in: PubMed
    Score: 0.525
  12. Tissue engineered vascular grafts: current state of the field. Expert Rev Med Devices. 2017 May; 14(5):383-392.
    View in: PubMed
    Score: 0.522
  13. Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model. J Thorac Cardiovasc Surg. 2017 04; 153(4):924-932.
    View in: PubMed
    Score: 0.505
  14. Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model. PLoS One. 2016; 11(7):e0158555.
    View in: PubMed
    Score: 0.494
  15. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. J Thorac Cardiovasc Surg. 2012 Mar; 143(3):696-703.
    View in: PubMed
    Score: 0.361
  16. Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method. Tissue Eng Part C Methods. 2011 Oct; 17(10):993-8.
    View in: PubMed
    Score: 0.348
  17. Late-term results of tissue-engineered vascular grafts in humans. J Thorac Cardiovasc Surg. 2010 Feb; 139(2):431-6, 436.e1-2.
    View in: PubMed
    Score: 0.315
  18. The tissue-engineered vascular graft using bone marrow without culture. J Thorac Cardiovasc Surg. 2005 May; 129(5):1064-70.
    View in: PubMed
    Score: 0.227
  19. [First successful clinical application of tissue engineered blood vessel]. Kyobu Geka. 2002 May; 55(5):368-73.
    View in: PubMed
    Score: 0.184
  20. Extruded poly (glycerol sebacate) and polyglycolic acid vascular graft forms a neoartery. J Tissue Eng Regen Med. 2022 04; 16(4):346-354.
    View in: PubMed
    Score: 0.181
  21. Assessment of decellularized pericardial extracellular matrix and poly(propylene fumarate) biohybrid for small-diameter vascular graft applications. Acta Biomater. 2020 07 01; 110:68-81.
    View in: PubMed
    Score: 0.160
  22. Spontaneous reversal of stenosis in tissue-engineered vascular grafts. Sci Transl Med. 2020 04 01; 12(537).
    View in: PubMed
    Score: 0.159
  23. Different degradation rates of nanofiber vascular grafts in small and large animal models. J Tissue Eng Regen Med. 2020 02; 14(2):203-214.
    View in: PubMed
    Score: 0.157
  24. In Vitro Endothelialization of Biodegradable Vascular Grafts Via Endothelial Progenitor Cell Seeding and Maturation in a Tubular Perfusion System Bioreactor. Tissue Eng Part C Methods. 2016 07; 22(7):663-70.
    View in: PubMed
    Score: 0.123
  25. Rational design of an improved tissue-engineered vascular graft: determining the optimal cell dose and incubation time. Regen Med. 2016 Mar; 11(2):159-67.
    View in: PubMed
    Score: 0.120
  26. Effect of cell seeding on neotissue formation in a tissue engineered trachea. J Pediatr Surg. 2016 Jan; 51(1):49-55.
    View in: PubMed
    Score: 0.117
  27. TGFßR1 inhibition blocks the formation of stenosis in tissue-engineered vascular grafts. J Am Coll Cardiol. 2015 Feb 10; 65(5):512-4.
    View in: PubMed
    Score: 0.112
  28. Vessel bioengineering. Circ J. 2014; 78(1):12-9.
    View in: PubMed
    Score: 0.103
  29. Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts. Tissue Eng Part B Rev. 2013 Aug; 19(4):292-307.
    View in: PubMed
    Score: 0.097
  30. Characterization of the natural history of extracellular matrix production in tissue-engineered vascular grafts during neovessel formation. Cells Tissues Organs. 2012; 195(1-2):60-72.
    View in: PubMed
    Score: 0.089
  31. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J. 2011 Dec; 25(12):4253-63.
    View in: PubMed
    Score: 0.088
  32. Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI. FASEB J. 2011 Dec; 25(12):4150-61.
    View in: PubMed
    Score: 0.088
  33. Development of an operator-independent method for seeding tissue-engineered vascular grafts. Tissue Eng Part C Methods. 2011 Jul; 17(7):731-6.
    View in: PubMed
    Score: 0.086
  34. Vascular tissue engineering: towards the next generation vascular grafts. Adv Drug Deliv Rev. 2011 Apr 30; 63(4-5):312-23.
    View in: PubMed
    Score: 0.085
  35. Cell-seeding techniques in vascular tissue engineering. Tissue Eng Part B Rev. 2010 Jun; 16(3):341-50.
    View in: PubMed
    Score: 0.081
  36. Tissue-engineered vascular grafts: does cell seeding matter? J Pediatr Surg. 2010 Jun; 45(6):1299-305.
    View in: PubMed
    Score: 0.081
  37. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A. 2010 Mar 09; 107(10):4669-74.
    View in: PubMed
    Score: 0.079
  38. Tissue-engineered arterial grafts: long-term results after implantation in a small animal model. J Pediatr Surg. 2009 Jun; 44(6):1127-32; discussion 1132-3.
    View in: PubMed
    Score: 0.075
  39. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg. 2005 Jun; 129(6):1330-8.
    View in: PubMed
    Score: 0.057
  40. Extracardiac total cavopulmonary connection using a tissue-engineered graft. J Thorac Cardiovasc Surg. 2003 Dec; 126(6):1958-62.
    View in: PubMed
    Score: 0.051
  41. [Clinical practice of transplantation of regenerated blood vessels using bone marrow cells]. Nihon Naika Gakkai Zasshi. 2003 Sep 10; 92(9):1776-80.
    View in: PubMed
    Score: 0.051
  42. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials. 2003 Jun; 24(13):2303-8.
    View in: PubMed
    Score: 0.050
  43. Successful clinical application of tissue-engineered graft for extracardiac Fontan operation. J Thorac Cardiovasc Surg. 2003 Feb; 125(2):419-20.
    View in: PubMed
    Score: 0.049
  44. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng. 2001 Aug; 7(4):429-39.
    View in: PubMed
    Score: 0.044
  45. Cell-Laden Gradient Hydrogel Scaffolds for Neovascularization of Engineered Tissues. Adv Healthc Mater. 2021 04; 10(7):e2001706.
    View in: PubMed
    Score: 0.042
  46. Regenerative and durable small-diameter graft as an arterial conduit. Proc Natl Acad Sci U S A. 2019 06 25; 116(26):12710-12719.
    View in: PubMed
    Score: 0.038
  47. Principles of the Kenzan Method for Robotic Cell Spheroid-Based Three-Dimensional Bioprinting. Tissue Eng Part B Rev. 2017 06; 23(3):237-244.
    View in: PubMed
    Score: 0.032
  48. Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model. J Cardiothorac Surg. 2016 Dec 01; 11(1):163.
    View in: PubMed
    Score: 0.032
  49. TGF-ß receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation. FASEB J. 2016 07; 30(7):2627-36.
    View in: PubMed
    Score: 0.030
  50. 3D-Printed Biodegradable Polymeric Vascular Grafts. Adv Healthc Mater. 2016 Feb 04; 5(3):319-325.
    View in: PubMed
    Score: 0.030
  51. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg. 2008 Sep; 248(3):370-7.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.